2m 2m 2m 2m 2m 2m 2m
OUTLOOK THRPTCS (OTLK)
NASDAQ
$0.82+$0.007 (+0.89%)
Price as of Jun 03, 2026 7:59 PM EDT- $88.2MMarket Cap
- -57.60%1-Year Change
- BiotechnologyIndustry
OUTLOOK THRPTCS (OTLK)
$0.82+$0.007 (+0.89%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4M N/A | N/A N/A | -1.6M +4.86% | -1.5M +58.89% | |
Cost of Revenue | 1.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 57,205 N/A | 0 +100.00% | -1.6M +4.86% | -1.5M +58.89% | |
Sales and Marketing Expense | 39.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -27.2M -34.92% | -41.8M +57.88% | -26.5M -37.51% | -42.3M +8.66% | |
Depreciation and Amortization Expense | 117,052 +2.80% | 113,859 +157.67% | 44,188 -78.41% | 204,694 -21.91% | |
Total Operating Expenses | 1.4M -95.47% | 29.9M +12.25% | 26.7M +28.61% | 20.7M -59.90% | |
Operating Profit | -67.1M -6.47% | -71.7M +34.97% | -53.1M -15.77% | -63.1M +21.93% | |
Interest Income | 89,738 -90.10% | 906,150 N/A | N/A N/A | N/A N/A | |
Interest Expense | -283,128 N/A | N/A N/A | -1.6M +4.86% | -1.5M +58.89% | |
Interest Income and Expense and Net | -193,390 -121.34% | 906,150 +158.10% | -1.6M +4.86% | -1.5M +58.89% | |
Total Nonoperating Income and Expense | -283,128 N/A | N/A N/A | -1.6M +4.86% | -1.5M +58.89% | |
Income before Taxes | -64.0M -15.11% | -75.4M +27.78% | -59.0M -10.70% | -66.0M +24.24% | |
Income Taxes | -1.6M -55,522.46% | 2,800 0.00% | 2,800 0.00% | 2,800 +40.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -62.4M -17.17% | -75.4M +27.78% | -59.0M -10.70% | -66.1M +24.24% | |
Net Income from Continuing Operations Applicable to Common | -62.4M -17.17% | -75.4M +27.78% | -59.0M -10.70% | -66.1M +24.24% | |
Basic EPS and Net Income | -1.79 -55.91% | -4.06 +1,591.67% | -0.24 -22.58% | -0.31 -11.43% | |
Diluted EPS and Net Income | -1.79 -55.91% | -4.06 +1,591.67% | -0.24 -22.58% | -0.31 -11.43% | |
Basic Weighted Average Shares | 34.8M +87.59% | 18.5M -92.59% | 250.2M +17.96% | 212.1M +38.91% | |
Diluted Weighted Average Shares | 34.8M +87.59% | 18.5M -92.59% | 250.2M +17.96% | 212.1M +38.91% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.1M -45.85% | 14.9M -36.19% | 23.4M +34.46% | 17.4M +20.17% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8.1M -45.85% | 14.9M -36.19% | 23.4M +34.46% | 17.4M +20.17% | |
Total Current Assets | 17.4M -36.57% | 27.4M -11.50% | 31.0M +12.57% | 27.5M +27.95% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | 1.1M +18.11% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 163,625 0.00% | |
Total Long-Term Assets | 417,523 -4.95% | 439,283 -12.37% | 501,299 +279.73% | 132,015 -24.39% | |
Total Assets | 18.6M -35.52% | 28.8M -10.77% | 32.3M +13.23% | 28.5M +25.06% | |
Income Taxes Payable | 302,000 -83.73% | 1.9M 0.00% | 1.9M 0.00% | 1.9M 0.00% | |
Total Short-Term Debt | 29.9M +1.72% | 29.4M -17.19% | 35.6M +225.71% | 10.9M +141.66% | |
Total Current Liabilities | 45.8M +7.66% | 42.6M -8.94% | 46.7M +136.86% | 19.7M +192.20% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 35.6M +226.58% | 10.9M 0.00% | |
Total Long-Term Liabilities | 5.0M -91.65% | 59.3M +954,168.13% | 6,219 -92.61% | 84,133 -84.70% | |
Total Liabilities | 50.8M -50.17% | 101.9M +118.02% | 46.7M +136.16% | 19.8M +8.72% | |
Retained Earnings | -605.7M +11.49% | -543.3M +16.11% | -467.9M +14.42% | -408.9M +19.26% | |
Total Stockholders Equity | -32.2M -55.95% | -73.1M +406.15% | -14.4M -265.26% | 8.7M +89.62% | |
Total Shares Outstanding | 53.9M +125.42% | 23.9M -90.81% | 260.3M +14.49% | 227.3M +28.82% | |
Cash Flow | |||||
Cash from Operating Activities | -51.8M -24.66% | -68.8M +60.08% | -43.0M -24.18% | -56.7M +4.46% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 45.0M -25.43% | 60.3M +23.20% | 49.0M -17.83% | 59.6M +6.05% | |
Financials Ratio | |||||
Gross Margin | 4.05% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4,744.25% N/A | N/A N/A | 3,406.09% -19.67% | 4,240.18% -23.26% | |
Return on Assets | -263.36% +6.79% | -246.60% +27.16% | -193.93% -24.63% | -257.32% +2.96% | |
Return on Equity | 118.61% -31.14% | 172.24% -91.68% | 2,069.13% +309.00% | -989.99% -30.79% | |
Revenue Growth | N/A N/A | N/A N/A | -4.86% -91.75% | -58.89% -47.18% | |
Current Ratio | 0.38 -41.08% | 0.64 -2.81% | 0.66 -52.48% | 1.39 -56.21% | |
Cash Ratio | 0.18 -49.71% | 0.35 -29.92% | 0.50 -43.23% | 0.88 -58.87% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | -4.92 -297.35% | 2.50 -25.35% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 2.20 +188.05% | 0.76 +13.18% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow